Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,996.00
Bid: 1,995.00
Ask: 1,997.00
Change: 15.00 (0.76%)
Spread: 2.00 (0.10%)
Open: 1,987.00
High: 2,000.00
Low: 1,979.00
Prev. Close: 1,981.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks edge higher, AB Foods jumps on Primark expansion

Wed, 23rd Apr 2014 08:40

- AB Foods jumps on Primark expansion plans- Stocks rise, but upside limited- BoE minutes, economic data ahead- Chinese manufacturing PMI contracts againtechMARK 2,749.64 +0.41%FTSE 100 6,688.65 +0.10%FTSE 250 16,067.20 -0.09%UK stocks edged higher on Wednesday morning with Primark owner Associated British Foods leading the risers as markets extended gains after a surge the day before.AB Foods' share price jumped strongly this morning after the company announced plans to open its first Primark store in the States, as it rolls out the fast-growing fashion outlet overseas.The FTSE 100 was trading 0.1% higher at 6,689 in early trading today, though upside was limited after a 0.9% gain on Tuesday on the back of heightened M&A activity and bid speculation in the global pharmaceutical sector."The gains over the last few days have seen a welcome turn around after the initial weak start to the month, but now as we edge near to the top of recent range, traders are looking hesitant in case sellers emerge again," said Dealer Jonathan Sudaria from Capital Spreadex.The mood is likely to remain cautious ahead of a host of data and macro-economic announcements during the session, including the minutes of the Bank of England meeting this morning. Figures on UK public finances, a reading on business optimism from the CBI and US housing data will be in focus today, along with any developments in the ongoing Ukraine crisis.Markets were also reacting to yet another contraction in the Chinese manufacturing sector this month. A private survey out from HSBC and Markit showed the 'flash' reading of the purchasing managers' index for Chinese manufacturing was 48.3 in April, up slightly from 48 in March but still below the key 50-point threshold that separates contraction and growth.AB Foods jumps on US expansion, resultsAB Foods was trading 9% higher after saying that it would open new Primark stores in north-east US. The chain, which already has stores in nine countries in Western Europe, has signed a lease for 70,000 square feet of selling space in Boston and will open the shop towards the end of 2015. Further stores are planned across the wider region through to the middle of 2016.The company also reported a 4% increase in adjusted pre-tax profits to £468m for the 24 weeks to March 1st, helped by a 26% jump in operating profits at Primark.Antofagasta was trading firmly in the red this morning after going ex-dividend, meaning that from today new investors won't be able to obtain the company's latest payout. FTSE 100-listed peers Aggreko, BG Group, Centrica, Legal & General, Mondi, Old Mutual and Rolls-Royce were also trading without the rights to their latest dividends this morning.A number of FTSE 250 stocks were also lower after going ex-dividend, including Hikma, Drax, Kentz and Tullett Prebon.AstraZeneca was continuing to rise on speculation that US pharmaceutical peer Pfizer could offer as much as £60bn to buy the company, representing the largest foreign takeover of a UK business on record. The stock, which rose 5% yesterday, was making solid gains this morning.Similarly, GlaxoSmithKline was extending gains after yesterday unveiling a massive three-part deal with Swiss firm Novartis, under which shareholders will receive a £4bn a capital return.Retail-focused property group Hammerson rose after giving a confident outlook, saying that an improving UK recovery filtered through to demand in the first quarter.High street sporting goods retailer Sports Direct fell after seeing a slight slowdown in growth in the fourth quarter. The company also warned of "further uncertainty" arising from its decision to cancel a controversial bonus payout to founder Mike Ashley earlier this month.FTSE 100 - RisersAssociated British Foods (ABF) 2,970.00p +9.11%AstraZeneca (AZN) 4,045.00p +2.15%Wolseley (WOS) 3,431.00p +2.08%Shire Plc (SHP) 3,195.00p +1.56%Admiral Group (ADM) 1,384.00p +1.54%Royal Mail (RMG) 529.50p +1.44%Hammerson (HMSO) 580.50p +1.13%Johnson Matthey (JMAT) 3,274.00p +1.05%Tesco (TSCO) 295.35p +1.01%GlaxoSmithKline (GSK) 1,655.00p +0.91%FTSE 100 - FallersAntofagasta (ANTO) 794.00p -5.98%Centrica (CNA) 330.00p -4.32%Morrison (Wm) Supermarkets (MRW) 197.70p -3.14%Old Mutual (OML) 197.90p -2.99%Legal & General Group (LGEN) 206.70p -2.59%ARM Holdings (ARM) 964.00p -1.93%Sports Direct International (SPD) 815.50p -1.75%Mondi (MNDI) 988.50p -1.54%Aberdeen Asset (ADN) 437.70p -1.37%Ashtead Group (AHT) 891.50p -1.00%FTSE 250 - RisersSpirent Communications (SPT) 101.60p +5.18%Thomas Cook Group (TCG) 180.00p +3.69%Perform Group (PER) 245.00p +2.94%Merlin Entertainments (MERL) 359.50p +2.07%FirstGroup (FGP) 131.00p +1.71%Polymetal International (POLY) 617.00p +1.48%SEGRO (SGRO) 349.80p +1.39%Synthomer (SYNT) 269.80p +1.28%Caledonia Investments (CLDN) 2,100.00p +1.20%Centamin (DI) (CEY) 53.50p +1.13%FTSE 250 - FallersDrax Group (DRX) 689.00p -8.92%Moneysupermarket.com Group (MONY) 179.20p -3.97%Tullett Prebon (TLPR) 300.50p -3.72%Balfour Beatty (BBY) 289.30p -3.50%Vesuvius (VSVS) 433.20p -2.65%Man Group (EMG) 100.50p -2.52%International Public Partnerships Ltd. (INPP) 126.30p -2.32%Rathbone Brothers (RAT) 1,967.00p -1.65%Laird (LRD) 286.60p -1.55%Renishaw (RSW) 1,900.00p -1.55%BC
More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.